Efficacy and safety of short‐term dual antiplatelet therapy (≤6 months) after percutaneous coronary intervention for acute coronary syndrome: A systematic review and meta‐analysis of randomized controlled trials

BACKGROUND: Patients who undergo percutaneous coronary intervention (PCI) for acute coronary syndrome (ACS) are at increased risk for subsequent ischemic events. HYPOTHESIS: Short‐term dual antiplatelet therapy (DAPT) (≤6 months) is inferior to standard or long‐term DAPT in patients who undergo PCI...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Clin Cardiol
Hlavní autoři: Misumida, Naoki, Abo‐Aly, Mohamed, Kim, Sun Moon, Ogunbayo, Gbolahan O., Abdel‐Latif, Ahmed, Ziada, Khaled M.
Médium: Artigo
Jazyk:Inglês
Vydáno: Wiley Periodicals, Inc. 2018
Témata:
Clinical Investigations
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6489918/
https://ncbi.nlm.nih.gov/pubmed/30225978
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.23075
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky